{"doi":"10.1016/j.bmcl.2021.127854","title":"Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases","abstract":null,"journal":"Bioorganic & Medicinal Chemistry Letters","year":2021,"id":14614,"datarank":0.806173061604623,"base_score":3.1354942159291497,"endowment":3.1354942159291497,"self_citation_contribution":0.47032413238937254,"citation_network_contribution":0.3358489292152504,"self_endowment_contribution":0.47032413238937254,"citer_contribution":0.3358489292152504,"corpus_percentile":null,"corpus_rank":null,"citation_count":22,"citer_count":18,"citers_with_citation_signal":17,"citers_with_endowment":17,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":114670,"name":"Richard F. Clark","orcid":null,"position":1,"is_corresponding":false},{"id":114671,"name":"Vikram Bhat","orcid":null,"position":2,"is_corresponding":false},{"id":114672,"name":"T. Matthew Hansen","orcid":null,"position":3,"is_corresponding":false},{"id":114673,"name":"Loren M. Lasko","orcid":null,"position":4,"is_corresponding":false},{"id":114674,"name":"Kenneth D. Bromberg","orcid":null,"position":5,"is_corresponding":false},{"id":114675,"name":"Vlasios Manaves","orcid":null,"position":6,"is_corresponding":false},{"id":114676,"name":"Mikkel Algire","orcid":null,"position":7,"is_corresponding":false},{"id":114677,"name":"Ruth Martin","orcid":null,"position":8,"is_corresponding":false},{"id":89815,"name":"Wei Qiu","orcid":"0000-0001-8093-3094","position":9,"is_corresponding":false},{"id":114678,"name":"Maricel Torrent","orcid":null,"position":10,"is_corresponding":false},{"id":114679,"name":"Clarissa G. Jakob","orcid":null,"position":11,"is_corresponding":false},{"id":15683,"name":"Hong Liu","orcid":"0000-0003-3685-6268","position":12,"is_corresponding":false},{"id":67,"name":"Philip A. Cole","orcid":"0000-0001-6873-7824","position":13,"is_corresponding":false},{"id":114680,"name":"Ronen Marmorstein","orcid":null,"position":14,"is_corresponding":false},{"id":114681,"name":"Edward A. Kesicki","orcid":null,"position":15,"is_corresponding":false},{"id":114682,"name":"Albert Lai","orcid":null,"position":16,"is_corresponding":false},{"id":114683,"name":"Michael R. Michaelides","orcid":null,"position":17,"is_corresponding":false},{"id":114669,"name":"Zhiqin Ji","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.1354942159291497,"endowment":3.1354942159291497,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33631370","pmcid":"PMC8392731","openalex_id":"https://openalex.org/W3132060957","authors":[],"funders":[{"funder_name":"NIA NIH HHS","grant_id":"P01 AG031862","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R01 GM062437","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R35 GM118090","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R37 GM062437","title":null},{"funder_name":"National Institutes of Health","grant_id":"5R35GM118090-05","title":"Molecular Mechanisms and inhibition of Protein Acetyltransferases"},{"funder_name":"National Institutes of Health","grant_id":"5R01GM062437-08","title":"Mechanisms & Inhibition of Histone Acetyltransferases"},{"funder_name":"Argonne National Laboratory","grant_id":"","title":null},{"funder_name":"University of Pennsylvania Perelman School of Medicine","grant_id":"","title":null},{"funder_name":"Harvard Medical School","grant_id":"","title":null}],"total_grants":9,"fwci":1.2201,"citation_percentile":0.78308567,"influential_citations":1,"citation_trend":[{"year":2021,"count":3},{"year":2022,"count":2},{"year":2023,"count":4},{"year":2024,"count":6},{"year":2025,"count":7}],"oa_status":"green","license":"Elsevier TDM","oa_locations":[{"url":"https://www.osti.gov/biblio/1815229","host_type":"repository"},{"url":"https://www.sciencedirect.com/science/article/am/pii/S0960894X21000809","host_type":"BRONZE"},{"url":"https://www.osti.gov/biblio/1815229","host_type":"repository"},{"url":"https://api.elsevier.com/content/article/PII:S0960894X21000809?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0960894X21000809?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.bmcl.2021.127854","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33631370","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8392731","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392731","host_type":""},{"url":"https://dx.doi.org/10.1016/j.bmcl.2021.127854","host_type":""}],"fields_of_study":["Protein Degradation and Inhibitors","Ubiquitin and proteasome pathways","Genomics and Chromatin Dynamics","Medicine","Chemistry","0301 basic medicine","0303 health sciences","03 medical and health sciences","Administration, Oral","Biological Availability","CREB-Binding Protein","Dose-Response Relationship, Drug","Drug Discovery","E1A-Associated p300 Protein","Enzyme Inhibitors","Humans","Hydantoins","Molecular Structure","Spiro Compounds","Structure-Activity Relationship"],"mesh_terms":["Administration, Oral","Biological Availability","Dose-Response Relationship, Drug","Enzyme Inhibitors","Humans","Hydantoins","Spiro Compounds","Structure-Activity Relationship","Molecular Structure","E1A-Associated p300 Protein","CREB-Binding Protein","Drug Discovery"],"keywords":["Histone Acetyltransferases","Chemistry","Histone acetyltransferase","Acetyltransferase","CREB-binding protein","Acetylation","Acetyltransferases","Histone","P300-CBP Transcription Factors","PCAF","Biochemistry","Histone deacetylase","Enzyme","CREB","Pharmacology","Transcription factor","Biology","Gene","CBP","P300","Spirohydantoin","Dose-Response Relationship, Drug","Molecular Structure","Hydantoins","Administration, Oral","Biological Availability","Structure-Activity Relationship","Drug Discovery","Humans","Spiro Compounds","Enzyme Inhibitors","E1A-Associated p300 Protein"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-01T13:02:49.500423Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}